Wondfo’s Innovative Solutions and Products, Drive Health Care Forward! -- MEDICA - World Forum for Medicine

16.11.2020

Guangzhou Wondfo Biotech Co., Ltd

Wondfo’s Innovative Solutions and Products, Drive Health Care Forward!

This year’s MEDICA takes place as a virtual exhibition on November 16-19. Wondfo presents to you a series of innovative solutions and products that drive health care forward.

Wondfo sincerely welcomes you to visit our eBooth and have deep communication on our products and solutions with our team via phone, online video…during the exhibition.

 HIGHLIGHT ONE: 1㎡ Intelligent POCT Lab - Confined space with infinite potential application

1㎡Intelligent POCT Lab is a rapid test lab that takes up only one square meter of space. It is a very good integration and smart use of Wondfo’s technology platforms (including the colloid gold, fluorescence, chemiluminescence, dry biochemistry, electrochemistry, molecules), which are well-known for the small and convenient devices, stable and high-quality reagents, and rapid detection results.

The lab is also digitalized. Closed-loop intelligent management of multiple devices, single lab, and management centers is realized by data interconnection.

HIGHLIGHT TWO: A Comprehensive COVID-19 Diagnostic Solution

Wondfo has been working across the company since the outbreak and devoting all available resources to developing products that can effectively help fight against the pandemic.

Through continuous efforts, Wondfo has been successfully developed multiple diagnostic products based on three professional and widely recommended methods – nucleic acid, antigen, and antibody.

Wondfo COVID-19 solution integrating all Wondfo’s COVID-19 diagnostic products can help the confirmation, treatment, and prognosis of COVID-19 infection.

HIGHLIGHT THREE: New Product with New Edges

Finecare™ FIA Meter Ⅱ Plus SE is one of Wondfo's newly launched products this year, with a broad assay menu – Diabetic & Renal injury Markers, Thyroid function, Fertility, Cardiac Markers, inflammation Markers, Tumor Markers.

It is small in size, with a dimension of 239*278*148 mm, and light in weight (3.3kg). It also has a built-in battery, making it convenient to carry and use. The device is ideal for various POCT settings where the space is limited, such as pharmacies, GP office, or where the external power supply is difficult to access.

Beyond the above, a wide range of infectious disease detection reagents will also be found on Wondfo's eBooth, including Hepatitis, HIV, Dengue, Malaria, H.Pylori, Strep A, Enterovirus, etc.

About Wondfo

Guangzhou Wondfo Biotech Co., Ltd., a fast-growing POCT leader in China, has been focusing on the R&D, production, sales, and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions since founded in 1992.

Today, Wondfo has more than 3000 employees, 20 subsidiaries worldwide, and a wide range of rapid diagnostic reagents and medical devices for the quantitative determination of clinical markers used for early identification of cardiovascular disease, diabetes, tumor, inflammation, infectious disease, etc.

It is our commitment to safeguarding the health and improving lives with better products, services, and solutions. We’ll continue to innovate and shape the future of POCT and healthcare.

Exhibitor Data Sheet